Fmoc-L-天冬氨酸 1-烯丙酯，Fmoc-Asp-OAll；≥97.0% (HPLC)
最近浏览商品
-
![图片 (R)-(-)-环氧氯丙烷 [表氯醇]，(R)-(−)-Epichlorohydrin；99%](https://www.bszh.cn/images/thumbs/0007437_r-r-epichlorohydrin99_32.png "显示明细 (R)-(-)-环氧氯丙烷 [表氯醇]，(R)-(−)-Epichlorohydrin；99%")
(R)-(-)-环氧氯丙烷 [表氯醇]，(R)-(−)-Epichlorohydrin；99% -
![图片 三(2,2′-联吡啶二氯钌(II)六水合物，Tris(2,2′-bipyridyl)dichlororuthenium(II) hexahydrate [Ru(BPY)3]；powder](https://www.bszh.cn/images/thumbs/0014427_22-iitris22-bipyridyldichlororutheniumii-hexahydrate-rubpy3powder_32.png "显示明细 三(2,2′-联吡啶二氯钌(II)六水合物，Tris(2,2′-bipyridyl)dichlororuthenium(II) hexahydrate [Ru(BPY)3]；powder")
三(2,2′-联吡啶二氯钌(II)六水合物，Tris(2,2′-bipyridyl)dichlororuthenium(II) hexahydrate [Ru(BPY)3]；powder -
![图片 (R)-4-硝基苄基 2-重氮-4-((2R,3S)-3-((R)-1-羟基-乙基)-4-羰基氮杂环丁烷-2-基)-3-羰基戊酸酯 [美罗培南中间体F9]，(R)-4-Nitrobenzyl 2-diazo-4-((2R,3S)-3-((R)-1-hydroxy-ethyl)-4-oxoazetidin-2-yl)-3-oxopentanoate；≥98%](https://www.bszh.cn/images/thumbs/0020388_r-4-2-4-2r3s-3-r-1-4-2-3-f9r-4-nitrobenzyl-2-diazo-4-2r3s-3-r-1-hydroxy-ethyl-4-oxoazetidin-2-yl-3-o_32.png "显示明细 (R)-4-硝基苄基 2-重氮-4-((2R,3S)-3-((R)-1-羟基-乙基)-4-羰基氮杂环丁烷-2-基)-3-羰基戊酸酯 [美罗培南中间体F9]，(R)-4-Nitrobenzyl 2-diazo-4-((2R,3S)-3-((R)-1-hydroxy-ethyl)-4-oxoazetidin-2-yl)-3-oxopentanoate；≥98%")
(R)-4-硝基苄基 2-重氮-4-((2R,3S)-3-((R)-1-羟基-乙基)-4-羰基氮杂环丁烷-2-基)-3-羰基戊酸酯 [美罗培南中间体F9]，(R)-4-Nitrobenzyl 2-diazo-4-((2R,3S)-3-((R)-1-hydroxy-ethyl)-4-oxoazetidin-2-yl)-3-oxopentanoate；≥98% -
1,8-二羟基蒽醌，1,8-Dihydroxyanthraquinone；phyproof® Reference Substance, ≥90.0% (HPLC)
